Immune Surveillance: A Balance Between Pro- and Anti-tumor Immunity

Por Ostrand-Rosenberg, Suzanne
Publicado em 2008

Cancer and complement

Por Ostrand-Rosenberg, Suzanne
Publicado em 2008

Inflammation, immune suppression, and tumor progression

Por Ostrand-Rosenberg, Suzanne
Publicado em 2013

Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity

Por Ostrand-Rosenberg, Suzanne
Publicado em 2010

Tolerance and Immune Suppression in the Tumor Microenvironment

Por Ostrand-Rosenberg, Suzanne
Publicado no Cell Immunol (2015)

Radiotherapy Both Promotes and Inhibits Myeloid-Derived Suppressor Cell Function: Novel Strategies for Preventing the Tumor-Protective Effects of Radiotherapy

Por Suzanne Ostrand-Rosenberg, Suzanne Ostrand-Rosenberg, Lucas A. Horn, Nicholas G. Ciavattone
Publicado em 2019-04-01

H-2 antigen expression on teratocarcinoma cells passaged in genetically resistant mice is regulated by lymphoid cells

Por Ostrand-Rosenberg, Suzanne, Cohn, Allen
Publicado em 1981

Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer

Por Ostrand-Rosenberg, Suzanne, Sinha, Pratima
Publicado em 2009

Coordinated regulation of myeloid cells by tumours

Por Gabrilovich, Dmitry I., Ostrand-Rosenberg, Suzanne, Bronte, Vincenzo
Publicado em 2012

A Soluble Form of CD80 Enhances Antitumor Immunity by Neutralizing Programmed Death Ligand-1and Simultaneously Providing Costimulation

Por Haile, Samuel T., Horn, Lucas A., Ostrand-Rosenberg, Suzanne
Publicado em 2014

The Programmed Death-1 Immune Suppressive Pathway: Barrier to Anti-Tumor Immunity()

Por Ostrand-Rosenberg, Suzanne, Horn, Lucas A., Haile, Samuel T.
Publicado em 2014

Novel strategies for inhibiting PD-1 pathway-mediated immune suppression while simultaneously delivering activating signals to tumor-reactive T cells

Por Ostrand-Rosenberg, Suzanne, Horn, Lucas A., Alvarez, Juan A.
Publicado no Cancer Immunol Immunother (2015)

Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment

Por Parker, Katherine H., Beury, Daniel W., Ostrand-Rosenberg, Suzanne
Publicado no Adv Cancer Res (2015)

High-mobility group box protein 1 promotes the survival of myeloid-derived suppressor cells by inducing autophagy

Por Parker, Katherine H., Horn, Lucas A., Ostrand-Rosenberg, Suzanne
Publicado no J Leukoc Biol (2016)

Tumor-Induced Myeloid-derived Suppressor Cell Function is Independent of IFNγ and IL-4Rα

Por Sinha, Pratima, Parker, Katherine H., Horn, Lucas, Ostrand-Rosenberg, Suzanne
Publicado em 2012

Detection of the circulating antibodies to teratocarcinomadefined antigens in patients with testicular tumours.

Por Teodorczyk-Injeyan, J, Jewett, M A, Burke, C A, Ostrand-Rosenberg, S
Publicado em 1980

Major Histocompatibility Complex Class II(+) Invariant Chain Negative Breast Cancer Cells Present Unique Peptides that Activate Tumor-specific T Cells from Breast Cancer Patients

Por Chornoguz, Olesya, Gapeev, Alexei, O'Neill, Michael C., Ostrand-Rosenberg, Suzanne
Publicado em 2012

Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression

Por Ostrand-Rosenberg, Suzanne, Sinha, Pratima, Beury, Daniel W., Clements, Virginia K.
Publicado em 2012

Exosomes from myeloid derived suppressor cells carry biologically active proteins

Por Burke, Meghan, Choksawangkarn, Waeowalee, Edwards, Nathan, Ostrand-Rosenberg, Suzanne, Fenselau, Catherine
Publicado em 2013

Soluble CD80 Restores T Cell Activation and Overcomes Tumor Cell Programmed Death Ligand-1-mediated Immune Suppression()

Por Haile, Samuel T., Dalal, Sonia P., Clements, Virginia, Tamada, Koji, Ostrand-Rosenberg, Suzanne
Publicado em 2013